Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| INTEGRA LIFESCIENCES HOLDINGS CORPIART · Entity 2707 | Director | May 07, 2026 | May 11, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
INTEGRA LIFESCIENCES HOLDINGS CORP
Report date May 07, 2026 · Filed May 11, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 88,254 |
Reported balance
After 2026-05-09 transaction · row 1
1 source rowRow 1 · 2026-05-09 · Tax withholding · Disposed 882 · Balance 88,254 |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 17,700 |
Reported balance
After 2026-05-07 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-05-07 · Grant · Acquired 17,700 · Balance 17,700 F1: Grant of restricted stock units (RSUs) pursuant to the Integra LifeSciences Holdings Corporation (IART) Fifth Amended and Restated 2003 Equity Incentive Plan, as amended. Each RSU represents a contingent right to receive one share of IART common stock. F2: RSUs vest in full on the one-year anniversary of the grant date of May 7, 2026. |
Filing footnotes · ownership attribution and instrument terms
F1: Grant of restricted stock units (RSUs) pursuant to the Integra LifeSciences Holdings Corporation (IART) Fifth Amended and Restated 2003 Equity Incentive Plan, as amended. Each RSU represents a contingent right to receive one share of IART common stock.
F2: RSUs vest in full on the one-year anniversary of the grant date of May 7, 2026.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
SeaSpine Holdings Corp
Report date January 05, 2023 · Filed January 10, 2023
Section 16 reporting ended · disclosed 2023-01-10. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2023-01-05 transaction · row 1
1 source rowRow 1 · 2023-01-05 · Disposition to issuer · Disposed 88,592 · Balance 0 F1: Disposed of pursuant to the Agreement and Plan of Merger by and among the issuer, SeaSpine Holdings Corporation, which became effective on January 5, 2023, in exchange for 36,880 Orthofix MedicalInc. ("Orthofix") ordinary shares having a market value of $22.76 per share at the effective time of the merger. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $15.68 · Expires 2025-08-01 | Direct | 0 |
Reported balance
After 2023-01-05 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2023-01-05 · Disposition to issuer · Disposed 58,559 · Balance 0 F3: This option was assumed by Orthofix in the merger and replaced with an option to purchase 24,378 shares of Orthofix at a price of $37.67 per share. F2: The option vests as to 25% of the underlying shares on November 1, 2015 and the remaining 75% in three equal quarterly installments thereafter. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $17.18 · Expires 2026-01-01 | Direct | 0 |
Reported balance
After 2023-01-05 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2023-01-05 · Disposition to issuer · Disposed 3,858 · Balance 0 F5: This option was assumed by Orthofix in the merger and replaced with an option to purchase 1,606 shares of Orthofix at a price of $41.27 per share. F4: The option vests as to 50% of the underlying shares on February 1, 2016 and as to 25% of the underlying shares on each of May 1, 2016 and August 1, 2016. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $9.99 · Expires 2026-06-07 | Direct | 0 |
Reported balance
After 2023-01-05 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2023-01-05 · Disposition to issuer · Disposed 13,920 · Balance 0 F7: This option was assumed by Orthofix in the merger and replaced with an option to purchase 5,794 shares of Orthofix at a price of $24.00 per share. F6: The options vests in equal installments on each of September 7, 2016, December 7, 2016, March 7, 2016 and June 7, 2016. |
Filing footnotes · ownership attribution and instrument terms
F1: Disposed of pursuant to the Agreement and Plan of Merger by and among the issuer, SeaSpine Holdings Corporation, which became effective on January 5, 2023, in exchange for 36,880 Orthofix MedicalInc. ("Orthofix") ordinary shares having a market value of $22.76 per share at the effective time of the merger.
F2: The option vests as to 25% of the underlying shares on November 1, 2015 and the remaining 75% in three equal quarterly installments thereafter.
F3: This option was assumed by Orthofix in the merger and replaced with an option to purchase 24,378 shares of Orthofix at a price of $37.67 per share.
F4: The option vests as to 50% of the underlying shares on February 1, 2016 and as to 25% of the underlying shares on each of May 1, 2016 and August 1, 2016.
F5: This option was assumed by Orthofix in the merger and replaced with an option to purchase 1,606 shares of Orthofix at a price of $41.27 per share.
F6: The options vests in equal installments on each of September 7, 2016, December 7, 2016, March 7, 2016 and June 7, 2016.
F7: This option was assumed by Orthofix in the merger and replaced with an option to purchase 5,794 shares of Orthofix at a price of $24.00 per share.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 23, 2017 Filed May 25, 2017 20:25 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 782 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-035362 · doc4.xml · nonDerivative · entry 2 BRADLEY KEITH · CIK 0001188650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,277 Read SEC document |
| May 23, 2017 Filed May 25, 2017 20:25 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 3,544 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-035362 · doc4.xml · nonDerivative · entry 1 BRADLEY KEITH · CIK 0001188650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,495 Read SEC document |
| March 07, 2017 Filed Mar 9, 2017 17:12 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | Tax withholdingCommon Stock | 113 | $6.78 | $766.14 |
DisclosureSEC source: 0001637761-17-000051 · wf-form4_148907954960969.xml · nonDerivative · entry 1 BRADLEY KEITH · CIK 0001188650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,398 F1 · shares: Shares withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock that occurred on March 7, 2017. No shares were sold in connection with this transaction. Read SEC document |
| February 24, 2017 Filed Feb 28, 2017 21:09 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 65 | $42.33 | $2,751.45 |
DisclosureSEC source: 0001209191-17-015246 · doc4.xml · nonDerivative · entry 1 BRADLEY KEITH · CIK 0001188650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,951 F1 · balance_after: On December 21, 2016, the common stock of Integra LifeSciences Holdings Corporation split two-for-one, resulting in the reporting person's ownership of one additional share of common stock for each share of common stock owned as of that date, as reflected in the totals listed on this Form 4. Read SEC document |
| December 07, 2016 Filed Dec 8, 2016 20:07 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | Tax withholdingCommon Stock | 376 | $7.31 | $2,748.56 |
DisclosureSEC source: 0001637761-16-000147 · wf-form4_148122762682418.xml · nonDerivative · entry 1 BRADLEY KEITH · CIK 0001188650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,985 F1 · shares: Shares withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock that occurred on December 7, 2016. No shares were sold in connection with this transaction. Read SEC document |
| December 07, 2016 Filed Mar 9, 2017 17:10 UTC Amendment | SeaSpine Holdings Corp SPNE · Entity 120832 | Tax withholdingCommon Stock | 113 | $7.31 | $826.03 |
DisclosureSEC source: 0001637761-17-000049 · wf-form4a_148907942714721.xml · nonDerivative · entry 1 BRADLEY KEITH · CIK 0001188650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,511 F1 · shares: Shares withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock that occurred on December 7, 2016. No shares were sold in connection with this transaction. F2 · shares: The number of shares withheld to satisfy statutory tax withholding requirements on vesting of restricted stock that occurred on December 7, 2016 was overreported in the original filing. This amendment reports the correct number of shares withheld to cover taxes along with the corrected total amount of securities beneficially owned following this transaction. F2 · balance_after: The number of shares withheld to satisfy statutory tax withholding requirements on vesting of restricted stock that occurred on December 7, 2016 was overreported in the original filing. This amendment reports the correct number of shares withheld to cover taxes along with the corrected total amount of securities beneficially owned following this transaction. Read SEC document |
| November 24, 2016 Filed Nov 28, 2016 21:16 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 33 | $83.31 | $2,749.07 |
DisclosureSEC source: 0001209191-16-152178 · doc4.xml · nonDerivative · entry 1 BRADLEY KEITH · CIK 0001188650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,508 Read SEC document |
| September 07, 2016 Filed Nov 22, 2016 19:14 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | Tax withholdingCommon Stock | 376 | $10.67 | $4,011.92 |
DisclosureSEC source: 0001637761-16-000145 · wf-form4_147984204957623.xml · nonDerivative · entry 1 BRADLEY KEITH · CIK 0001188650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,361 F1 · shares: Shares withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock that occurred on September 7, 2016. No shares were sold in connection with this transaction. Read SEC document |
| September 07, 2016 Filed Mar 9, 2017 17:08 UTC Amendment | SeaSpine Holdings Corp SPNE · Entity 120832 | Tax withholdingCommon Stock | 113 | $10.67 | $1,205.71 |
DisclosureSEC source: 0001637761-17-000047 · wf-form4a_148907930248040.xml · nonDerivative · entry 1 BRADLEY KEITH · CIK 0001188650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,624 F1 · shares: Shares withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock that occurred on September 7, 2016. No shares were sold in connection with this transaction. F2 · shares: The number of shares withheld to satisfy statutory tax withholding requirements on vesting of restricted stock that occurred on September 7, 2016 was overreported in the original filing. This amendment reports the correct number of shares withheld to cover taxes along with the corrected total amount of securities beneficially owned following this transaction. F2 · balance_after: The number of shares withheld to satisfy statutory tax withholding requirements on vesting of restricted stock that occurred on September 7, 2016 was overreported in the original filing. This amendment reports the correct number of shares withheld to cover taxes along with the corrected total amount of securities beneficially owned following this transaction. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.